Pratap Neelakantan, David Marin, Mike Laffan, John Goldman, Jane Apperley, Dragana Milojkovic. Platelet dysfunction associated with ponatinib, a new pan BCR-ABL inhibitor with efficacy for chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitor therapy. Haematologica 2012;97(9):1444-1444; https://doi.org/10.3324/haematol.2012.064618.